Ownership history in CITIGROUP INC · 3 quarters on record
This page tracks every 13F SEC filing in which CITIGROUP INC reported a position in XILIO THERAPEUTICS INC (XLO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 258 | -65 | -20.1% | 0.00% | $217 | $11.80 |
| 2022 Q1 | REDUCED | 323 | -1,871 | -85.3% | 0.00% | $2K | $98.98 |
| 2021 Q4 | INITIATED | 2,194 | — | — | 0.00% | $35K | $224.00 |
As of 2025 Q4 — sorted by position size